Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing tranexamic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tranexamic acid adverse reaction |
Causative agent (attribute) |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to tranexamic acid (finding) |
Causative agent (attribute) |
False |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tranexamic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
acide tranexamique 100 mg/mL, ampoule de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tranexamic acid 100mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tranexamic acid 100mg/mL intravenous solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tranexamic acid 650 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to tranexamic acid (finding) |
Causative agent (attribute) |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tranexamic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tranexamic acid-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tranexamic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tranexamic acid 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tranexamic acid 650 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tranexamic acid 650 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tranexamic acid 100mg/mL conventional release solution for injection 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tranexamic acid 650 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tranexamic acid 500 mg oral tablet |
Has precise active ingredient |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tranexamic acid 500 milligram/5 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tranexamic acid 500 milligram/5 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only tranexamic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only tranexamic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tranexamic acid only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tranexamic acid 100 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tranexamic acid 100 mg/mL solution for injection |
Has precise active ingredient |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet |
Has precise active ingredient |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing etamsylate and tranexamic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only etamsylate and tranexamic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Etamsylate- and tranexamic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Etamsylate and tranexamic acid only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tranexamic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |